Titlebook: Cardio-Oncology; The Clinical Overlap Gretchen G. Kimmick,Daniel J. Lenihan,Dawn L. Hers Book 2017 Springer International Publishing Switze

領(lǐng)先

faction

,Gastrointestinale und abdominale Notf?lle,s the cellular and molecular mechanisms of radiation-induced heart disease, elucidating opportunities for intervention and prevention. Finally, recommendations for monitoring patients after radiotherapy and management of cardiac disease in patients with prior thoracic/breast neoplasms will be discussed.

Nerve-Block

Die Grunds?tze der Neugeborenenreanimationogic, and radiation therapies. Less well understood is the potential that cancers and cardiovascular diseases share common genetic susceptibilities. An appreciation of the converging epidemiology for cancer and heart disease will lay the foundation for developing prevention and treatment strategies.

易碎

,Gastrointestinale und abdominale Notf?lle,equire a dynamic partnership between oncologists and cardiologists, and the development of a new generation of “cardio-oncology” clinicians and investigators. Organized collaboration between oncologists, cardiologists, and regulatory agencies can support development of programs essential for anticancer agents with cardiac safety concerns.

cardiovascular

,St?rungen der Vitalfunktionen,chapter will address basic assessment and management of cardiac function and risk in cancer survivors. Best practices for assessment of survivors based on treatment modality (i.e., chemotherapy and/or radiation therapy) and host-related factors (i.e., age at diagnosis and pre-existing risk factors) are described.

amenity

Epidemiology of Cardio-Oncology,ogic, and radiation therapies. Less well understood is the potential that cancers and cardiovascular diseases share common genetic susceptibilities. An appreciation of the converging epidemiology for cancer and heart disease will lay the foundation for developing prevention and treatment strategies.

易改變

亞當(dāng)心理陰影

Cardiac Toxic Chemotherapy and Cancer Survivorship,chapter will address basic assessment and management of cardiac function and risk in cancer survivors. Best practices for assessment of survivors based on treatment modality (i.e., chemotherapy and/or radiation therapy) and host-related factors (i.e., age at diagnosis and pre-existing risk factors) are described.

Nomogram

Preoperative and Pre-transplant Cardiac Evaluation in the Cancer Patient,rd to patient-specific risk factors, the underlying disease, and the transplant procedures. Guidelines for the pre-transplant evaluation and prevention and monitoring for cardiovascular complications during the course of stem cell transplant are discussed.

FLAG

Radiation Therapy and Cardiotoxicity,s the cellular and molecular mechanisms of radiation-induced heart disease, elucidating opportunities for intervention and prevention. Finally, recommendations for monitoring patients after radiotherapy and management of cardiac disease in patients with prior thoracic/breast neoplasms will be discussed.